Features | Partner Sites | Information | LinkXpress
Sign In
CARDIOSTIM
Ampronix
Schiller

Circulatory Support System Aids Failing Hearts

By HospiMedica International staff writers
Posted on 10 Jul 2013
Image: The Synergy Circulatory Support System (Photo courtesy of CircuLite).
Image: The Synergy Circulatory Support System (Photo courtesy of CircuLite).
A surgically implanted micropump aids ambulatory chronic heart failure (CHCF) patients who not respond to optimal medical treatment.

The Synergy Circulatory Support System is designed to reverse HF symptoms in ambulatory patients, promoting significant hemodynamic improvements, including decreased pulmonary artery and pulmonary capillary wedge pressures and increased cardiac output. The device provides up to 4.25 liters of blood per minute, reducing the heart's workload while improving blood flow to the final organs. The system is surgically implanted using a mini-thoracotomy procedure and the micro-pump is placed in a pacemaker-like pocket. The procedure is intended to reduce the surgical risks associated with cardiopulmonary bypass support platforms needed to place current ventricular assist devices (VADs).

The micropump combines axial, centrifugal, and orthogonal flow paths with a single-stage impeller that is powered by an integrated brushless microelectric motor; the entire system is the size of a standard AA battery. The design allows the motor to be sealed, thus eliminating blood contact in the motor, as well as a proprietary self-washing flow path and an alternating speed algorithm, both designed to minimize the risk of thrombus formation in or around the rotor. The Synergy Circulatory Support System is a product of CircuLite (Aachen, Germany) and has received the European Community CE marking of approval.

“The latest version of the Synergy System was shown to improve hemodynamics and functional status with comparably low adverse event rates in chronic ambulatory heart failure patients,” said Professor Bart Meyns, MD, PhD, chief of cardiac surgery at the University Hospitals Leuven (Belgium), who conducted the study in the final 26 patients of the clinical Synergy CE-Mark Trial. “The System has the potential for broad application in earlier-stage patients, who are not sick enough to justify the risks associated with more surgically-invasive assist devices.”

“The final modifications we made to the Synergy System have made a significant clinical difference, which was demonstrated in our clinical trial,” said Paul Southworth, CEO of CircuLite. “We showed positive outcomes and we have lowered adverse events in comparison to larger devices.”

Related Links:
CircuLite



Channels

Surgical Techniques

view channel
Image: Sylys Surgical Sealant placed over an anastomosis staple line (Photo courtesy of Cohera Medical).

Elastic Sealant Protects Suture Line After Gastro Surgery

A novel synthetic sealant has been specifically designed to help reduce leaks after gastrointestinal (GI) anastomosis procedures. Sylys Surgical Sealant helps reduce anastomotic leakage in GI procedures... Read more

Women's Health

view channel

Elective Cesarean Section Risks Outweigh Benefits

A new review states that cesarean section is associated with increased risks to both mother and child, and should only be performed when it is clearly advantageous. Researchers at Ludwig-Maximilians-Universität (LMU; Munich, Germany) conducted a review of studies to understand the rising worldwide trend of elective cesarean... Read more

Hospital News

view channel
Image: The future site of the Springdale ACH campus on I-49, across from Arvest Ballpark (Photo courtesy of ACH).

Arkansas Children's Hospital to Develop Springdale Facility

Arkansas Children's Hospital (ACH; Little Rock, USA) has unveiled plans to develop a new hospital campus in Springdale, which will involve an investment of USD 184 million during the next five years.... Read more

Business

view channel
Image: The Centor 1-Clic vial (Photo courtesy of Centor).

Gerresheimer Buys Plastic Vials Maker Centor

Advanced healthcare glass and plastic products manufacturer Gerresheimer (Düsseldorf, Germany) has agreed to purchase plastic vial maker Centor (Perrysburg, OH, USA) for USD 725 million in cash.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.